Cargando…

Transcriptomic Landscape of Treatment—Naïve Ulcerative Colitis

BACKGROUND AND AIMS: Ulcerative colitis [UC] is a chronic inflammatory disease that effects the gastrointestinal tract and is considered one of the most prominent and common forms of inflammatory bowel disease [IBD]. This study aimed to define and describe the entire transcriptomic landscape in a we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taman, Hagar, Fenton, Christopher G, Hensel, Inga V, Anderssen, Endre, Florholmen, Jon, Paulssen, Ruth H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290885/ https://www.ncbi.nlm.nih.gov/pubmed/29040430 http://dx.doi.org/10.1093/ecco-jcc/jjx139

Ejemplares similares

Genome-wide DNA Methylation in Treatment-naïve Ulcerative Colitis
por: Taman, Hagar, et al.
Publicado: (2018)

DNA hypo-methylation facilitates anti-inflammatory responses in severe ulcerative colitis
por: Taman, Hagar, et al.
Publicado: (2021)

Transcriptional Signatures That Define Ulcerative Colitis in Remission
por: Fenton, Christopher G, et al.
Publicado: (2020)

Fibrosis Mediators in the Colonic Mucosa of Acute and Healed Ulcerative Colitis
por: Gundersen, Mona Dixon, et al.
Publicado: (2019)

Identifying predictive signalling networks for Vedolizumab response in ulcerative colitis
por: Singh, Amrinder, et al.
Publicado: (2022)

Identifying anti-TNF response biomarkers in ulcerative colitis using a diffusion-based signalling model
por: Singh, Amrinder, et al.
Publicado: (2021)

Anti-apoptotic genes and non-coding RNAs are potential outcome predictors for ulcerative colitis
por: Meng, Wei, et al.
Publicado: (2023)

Novel long non-coding RNAs of relevance for ulcerative colitis pathogenesis
por: Ray, Mithlesh Kumar, et al.
Publicado: (2022)

Methylation-Regulated Long Non-Coding RNA Expression in Ulcerative Colitis
por: Fenton, Christopher G., et al.
Publicado: (2023)

A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naïve and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression
por: Diab, Joseph, et al.
Publicado: (2019)

Ulcerative colitis: functional analysis of the in-depth proteome
por: Schniers, Armin, et al.
Publicado: (2019)

Transcriptomic analyses of treatment-naïve pediatric ulcerative colitis patients and exploration of underlying disease pathogenesis
por: Pang, Xiaoli, et al.
Publicado: (2023)

Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?
por: Cui, Guanglin, et al.
Publicado: (2022)

Real-life evaluation of histologic scores for Ulcerative Colitis in remission
por: Arkteg, Christian Børde, et al.
Publicado: (2021)

Mucosal Metabolomic Profiling and Pathway Analysis Reveal the Metabolic Signature of Ulcerative Colitis
por: Diab, Joseph, et al.
Publicado: (2019)

Granulomatous interstitial nephritis in a treatment-naïve patient with ulcerative colitis
por: Mohamed, Muner M. B., et al.
Publicado: (2022)

Hypo-osmotic stress induces the epithelial alarmin IL-33 in the colonic barrier of ulcerative colitis
por: Gundersen, Mona Dixon, et al.
Publicado: (2022)

Associations of breast cancer related exposures and gene expression profiles in normal breast tissue—The Norwegian Women and Cancer normal breast tissue study
por: Krum‐Hansen, Sanda, et al.
Publicado: (2023)

Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis
por: Sablich, Renato, et al.
Publicado: (2023)

Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis
por: Goll, Rasmus, et al.
Publicado: (2019)

Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis
por: Gundersen, Mona Dixon, et al.
Publicado: (2016)

Hepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjects
por: Isaksen, Victoria T., et al.
Publicado: (2016)

Serum IL-13 Predicts Response to Golimumab in Bio-Naïve Ulcerative Colitis
por: Kinoshita, Naohiko, et al.
Publicado: (2022)

Discovery and validation of mucosal TNF expression combined with histological score - a biomarker for personalized treatment in ulcerative colitis
por: Florholmen, Jon R., et al.
Publicado: (2020)

DNA methylation-associated colonic mucosal immune and defense responses in treatment-naïve pediatric ulcerative colitis
por: Harris, R Alan, et al.
Publicado: (2014)

Comparison of Long-term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis
por: Lee, Yong Il, et al.
Publicado: (2021)

Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study
por: Johnsen, Kay-Martin, et al.
Publicado: (2022)

Therapeutic landscape for ulcerative colitis: where is the Adacolumn(®) system and where should it be?
por: Vecchi, Maurizio, et al.
Publicado: (2013)

Golimumab for the treatment of ulcerative colitis
por: Löwenberg, Mark, et al.
Publicado: (2014)

Tacrolimus for the Treatment of Ulcerative Colitis
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2015)

Golimumab in the treatment of ulcerative colitis
por: Cunningham, Georgina, et al.
Publicado: (2019)

Golimumab for the treatment of ulcerative colitis
por: Flamant, Mathurin, et al.
Publicado: (2017)

Differences in Gene Expression between First and Third Trimester Human Placenta: A Microarray Study
por: Sitras, Vasilis, et al.
Publicado: (2012)

Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme
por: Winthrop, Kevin L, et al.
Publicado: (2020)

Single cell transcriptomic landscape of diabetic foot ulcers
por: Theocharidis, Georgios, et al.
Publicado: (2022)

Disease clearance in ulcerative colitis: Setting the therapeutic goals for future in the treatment of ulcerative colitis
por: Ramos, Laura, et al.
Publicado: (2023)

Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn’s disease
por: Rabe, H., et al.
Publicado: (2019)

Comparative efficacy of antitumor necrosis factor agents and tacrolimus in naïve steroid-refractory ulcerative colitis patients
por: Kitayama, Moto, et al.
Publicado: (2020)

Dose Escalation of Biologics in Biologic-Naïve Patients With Ulcerative Colitis: Outcomes From the ODESSA-UC Study
por: Ghosh, Sabyasachi, et al.
Publicado: (2023)

ULCERATIVE COLITIS
Publicado: (1969)

Cannot write session to /tmp/vufind_sessions/sess_6e0s05lt0e95n1ao63uv4smhr9